gPPP2R1A_Cas13_dsred
(Plasmid
#248705)
-
PurposeCas13 guideRNA for PPP2R1A
-
Depositing Lab
-
Depositing OrganizationUniversitaetsmedizin Goettingen
Located in Germany -
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 248705 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backboneCas13_DR1_dsRed-T2A-Puro
-
Backbone manufacturerDr. Christian J. Braun
- Backbone size w/o insert (bp) 9425
-
Vector typeLentiviral, CRISPR
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin and Bleocin (Zeocin), 100 & 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namePPP2R1A
-
gRNA/shRNA sequenceGAATAAAATAAAAACGGCACAGT
-
SpeciesH. sapiens (human)
-
Insert Size (bp)23
-
Entrez GenePPP2R1A (a.k.a. HJS2, MRD36, PP2A-Aalpha, PP2AA, PP2AAALPHA, PR65A)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site Unknown (unknown if destroyed)
- 5′ sequencing primer taccgagggcctatttccca
- (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
gPPP2R1A_Cas13_dsred was a gift from Günter Schneider (Addgene plasmid # 248705 ; http://n2t.net/addgene:248705 ; RRID:Addgene_248705) -
For your References section:
The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal Adenocarcinoma. Murr J, Schneider C, Duan N, Kose H, Rajamani A, He X, Buchloh J, Hintze C, Naik A, Goeke D, Rjasanow N, Krauss L, Nguyen A, Widholz SA, Schneeweis C, Trozzo R, Orben F, Mueller S, Ollinger R, Montero JJ, Dudek M, Knolle P, Kong B, Ellenrieder V, Contreras CT, Hessmann E, Grade M, Ghadimi M, Braun CJ, Rad R, Reichert M, Keller U, Schmid RM, Boutz PL, Saur D, Wirth M, Kramer OH, Schneider G. MedComm (2020). 2026 Jun 7;7(6):e70794. doi: 10.1002/mco2.70794. eCollection 2026 Jun. 10.1002/mco2.70794 PubMed 42266180